Try our Advanced Search for more refined results
Your firm must have an account to access this feature
June 18, 2020
Track this case
2:20-cv-02706
New York Eastern
Securities/Commodities
Class Action
Allyne R. Ross
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Investors in Chembio Diagnostics Inc., a company that sold now-revoked COVID-19 tests, have asked a New York federal court to give a final OK to an $8.1 million deal to end a lawsuit alleging that shareholders were harmed when the company's tests were taken off the market after being deemed ineffective by the U.S. Food and Drug Administration.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.